معرفی
Rachel Greenup is an Associate Professor of Surgery (Oncology) and Section Chief of Breast Surgical Oncology at Yale School of Medicine. She specializes in breast cancer care and serves as Co-Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center. Her clinical expertise focuses on providing state-of-the-art care for benign and malignant breast diseases, emphasizing patient-centered, high-quality, and cost-effective treatment approaches.
Dr. Greenup earned her MD from the Medical College of Wisconsin and an MPH from the University of Wisconsin. She completed her General Surgery residency at the Medical College of Wisconsin and a fellowship at Massachusetts General Hospital/Dana-Farber Cancer Institute/Brigham and Women's Hospital. Prior to Yale, she was an Associate Professor at Duke University School of Medicine, where she founded the Duke Breast Cancer Outcomes Research Group and contributed to health policy initiatives through the Duke Margolis Center for Health Policy.
Her research prioritizes understanding disparities in breast cancer care, financial toxicity, and patient decision-making. Key themes include racial/ethnic disparities in surgical outcomes, shared decision-making for breast cancer treatments, and the economic burden of cancer care. She serves on national committees such as the Alliance in Clinical Oncology Ethics, the American College of Surgeons Cancer Care Delivery Task Force, and the American Society of Breast Surgeons Legislative Committee.
Dr. Greenup has received notable awards, including the NIH BIRCWH Award (2016) and the American College of Surgeons/American Society of Breast Surgeons Health Policy Scholar designation (2017). Her work bridges clinical practice, policy, and research to improve equitable and efficient cancer care delivery.
She actively collaborates with institutions like the Center for Breast Cancer and COPPER Center at Yale. Her publications (e.g., on racial disparities in mastectomy, financial toxicity, and reconstructive preferences) reflect her commitment to advancing patient-centered, evidence-based oncology practices.
